Valo SPAC Presentation Deck
Clinical development: Valo's approach to trial optimization is being designed to
leverage patient datasets to identify sub-populations likely to benefit
INPUTS
1
Featurize patient
data & biomarker
signature
discovery
Opal
Patient
Data
Public
Datasets
Opal
Panomic
Data
Valo Los = likelihood of success
2
Identify pathway
dysfunction in
selected
subgroups
Opal
Panomic
Data
Opal
Opal
Chemistry Biological
& Biology knowledge
Data
graphs
3
Design pragmatic
clinical studies
Opal Chemistry
& Biology Data
Opal Biological
knowledge graphs
4
Monitor and adapt
study on ongoing
basis
Opal
Opal
Chemistry Biological
& Biology knowledge
graphs
Data
Opal
simulation
data
CLINICAL
DEVELOPMENT
Optimized,
higher LoS
trials
Valo's differentiated approach is designed to harness our proprietary data lake to precisely identify responder
populations (patients and time), enabling pragmatic studies - for faster and more effective studies
2Q21
21View entire presentation